Ambu A/S (OTCMKTS:AMBBY) Announces Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its quarterly earnings data on Thursday. The company reported $0.10 earnings per share for the quarter, Zacks reports. Ambu A/S had a return on equity of 4.11% and a net margin of 4.30%.

Ambu A/S Stock Performance

OTCMKTS:AMBBY opened at $19.01 on Friday. The company has a 50-day moving average price of $15.81 and a 200-day moving average price of $18.09. The stock has a market cap of $4.47 billion and a price-to-earnings ratio of 158.38. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09. Ambu A/S has a 12 month low of $13.02 and a 12 month high of $22.65.

Ambu A/S Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 23rd. Shareholders of record on Friday, December 6th were given a dividend of $0.0557 per share. The ex-dividend date was Friday, December 6th. Ambu A/S’s payout ratio is currently 25.00%.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.